Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
85 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

JAGX — Jaguar Health, Inc. Dilution Risk Tracker

Track JAGX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track JAGX — Get alerts when the score changes →

As of August 28, 2026, Jaguar Health, Inc. (JAGX) has a DilutionWatch DilutionScore of 85/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Jaguar Health, Inc. has a market capitalization of $2.33M, 171.35M shares outstanding, 12 institutional holders tracked. Stored dilution-related fields include 9.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊Float Risk
⚠️ Warrant Exposure
15
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 43%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 457% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
📉 Score Deterioration model 15%
• Score already CRITICAL (85/100) — events likely imminent
🔔 Track JAGX — Get forecast alerts →

Market Data

Market Cap$2.33M
Shares Outstanding171.35M
FloatN/A
Cash$7.28M
Debt$10.77M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 288.5% shares (2026Q1 vs prior)
12 institutional holders · 256.8K shares
#1 UBS Group AG 112.9K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 110.1K shares
#3 HRT FINANCIAL LP 15.2K shares
+ 9 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest87.2K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2025-12-31
8-K 8K EVENT 2026-05-04
8-K 8K EVENT 2026-04-21
4 INSIDER TRANSACTION 2026-03-12
Full SEC filing analysis available with free account

Recent News

No recent news

Factual JAGX Dilution Snapshot

Jaguar Health, Inc. (JAGX) has a DilutionScore of 85/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track JAGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking JAGX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for JAGX
JAGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.